FIELD OF INVENTION
The present invention relates to a method of lowering blood glucose level and a method of preventing or treating diseases including obesity and diabetes.
BACKGROUND OF INVENTION
Diabetes is one of so-called "lifestyle-related diseases", and the number of patients has been
FIELD OF INVENTION
This invention relates to novel compositions of matter. More particularly, the invention relates to cyclic hydrocarbons with an aminoalkyl sidechain that are useful for inhibiting phospholipase A2 and for treating diabetes and obesity.
INFORMATION DISCLOSURE
The important role of
FIELD OF INVENTION
This invention relates to novel compositions of matter. More particularly, the invention relates to cyclic hydrocarbons with an aminoalkyl sidechain that are useful for inhibiting phospholipase A2 and for treating diabetes and obesity.
INFORMATION DISCLOSURE
The important role of
FIELD OF INVENTION
This invention relates to novel compositions of matter. More particularly, the invention relates to cyclic hydrocarbons with an aminoalkyl sidechain that are useful for inhibiting phospholipase A2 and for treating diabetes and obesity.
INFORMATION DISCLOSURE
The important role of
FIELD OF INVENTION
This invention relates to novel compositions of matter. More particularly, the invention relates to cyclic hydrocarbons with an aminoalkyl sidechain that are useful for inhibiting phospholipase A2.
Information Disclosure
The important role of phospholipase A2 in mammalian
FIELD OF INVENTION
This invention relates to novel compositions of matter. More particularly, the invention relates to cyclic hydrocarbons with an aminoalkyl sidechain that are useful for inhibiting phospholipase A2 and for treating diabetes and obesity.
INFORMATION DISCLOSURE
The important role of
FIELD OF INVENTION
This invention relates to novel compositions of matter. More particularly, the invention relates to cyclic hydrocarbons with an aminoalkyl sidechain that are useful for inhibiting phospholipase A2 and for treating diabetes and obesity.
INFORMATION DISCLOSURE
The important role of
FIELD OF INVENTION
This invention encompasses novel cyclic hydrocarbons substituted with an aminoalkyl sidechain that are useful for inhibiting adverse physiological symptoms associated with phospholipase A2 and for treating hypoglycemia associated diseases such as diabetes and
FIELD OF INVENTION
This invention relates to novel compositions of matter. More particularly, the invention relates to cyclic hydrocarbons with an aminoalkyl sidechain that are useful for inhibiting phospholipase A2 and for treating diabetes and obesity.
INFORMATION DISCLOSURE
The important role of
FIELD OF THE INVENTION
This invention relates to novel compounds that are liver-selective glucocorticoid receptor antagonists and liver-selective thyroid receptor agonists, to methods of preparing such compounds, and to methods for using such compounds in the regulation of metabolism, especially
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to novel compounds which are thyroid receptor ligands, and are preferably selective for the thyroid hormone receptor .beta., to methods of preparing such compounds and to methods for using such compounds such as in the
TECHNICAL FIELD
The present invention relates to a novel 1-adamantyl azetidin-2-one derivative having an 11.beta.-hydroxy steroid dehydrogenase 1-inhibitory activity and a medicine comprising the same.
BACKGROUND ART
11.beta.-hydroxysteroid dehydrogenase (hereinafter, abbreviated as 11.beta.-HSD)1
TECHNICAL FIELD
The present invention relates to a quinoline compound having a melanin-concentrating hormone (hereinafter sometimes to be abbreviated as MCH) antagonistic action and useful as an agent for preventing or treating obesity and the like.
BACKGROUND ART
Feeding behavior is an
This Application is National Stage of International Application Ser. No. PCT/JP98/01753, filed Apr. 16, 1998.
TECHNICAL FIELD
The present invention relates to a medicine and, more particularly, to a thermogenic agent (thermogenesis accelerator) for use as a prophylactic and/or treating drug for
This application is the National Phase filing of International Patent Application No. PCT/JP00/06375, filed Sep. 19, 2000.
TECHNICAL FIELD
The present invention relates to a melanin-concentrating hormone antagonist which is useful as an agent for preventing or treating obesity, etc.
BACKGROUND
Najkompletnija baza ljekovitog bilja potpomognuta naukom
Radi na 55 jezika
Biljni lijekovi potpomognuti naukom
Prepoznavanje biljaka po slici
Interaktivna GPS karta - označite bilje na lokaciji (uskoro)
Pročitajte naučne publikacije povezane sa vašom pretragom
Pretražite ljekovito bilje po učincima
Organizirajte svoja interesovanja i budite u toku sa istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi. * Sve informacije temelje se na objavljenim naučnim istraživanjima